CNR1 and atherosclerosis: Recent studies have supported the role of CB1 and CB2, located systemically and in the cardiovascular system, as exhibiting both pathologic and protective effects depending on receptor agonism/antagonism[3] with a strong correlation for CB1 inhibition and therapeutic benefits in cardiovascular pathology.[4] The ECS has a functional role in coagulation and atherosclerosis.